![PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model](https://www.researchgate.net/profile/Elwin-Rombouts/publication/8625589/figure/fig2/AS:267478680993823@1440783295739/A-Double-exposure-simulation-radiograph-showing-the-positioning-of-the-thymic_Q320.jpg)
PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model
![PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model](https://www.researchgate.net/profile/Elwin-Rombouts/publication/8625589/figure/fig4/AS:267853706297398@1440872708978/Effect-of-DLI-on-average-blood-cell-parameters-1-SEM-in-BMT-recipients-pretreated-with_Q320.jpg)
PDF) Addition of treosulfan to a nonmyeloablative conditioning regimen results in enhanced chimerism and immunologic tolerance in an experimental allogeneic bone marrow transplant model
![Preventative treatment for GvHD in patients requiring haploidentical peripheral blood stem cell transplant: Preliminary findings from the phase II ANZHIT-1 study Preventative treatment for GvHD in patients requiring haploidentical peripheral blood stem cell transplant: Preliminary findings from the phase II ANZHIT-1 study](https://gvhdhub.com/media/images/4d/ba/fig1-gvhd.jpg)
Preventative treatment for GvHD in patients requiring haploidentical peripheral blood stem cell transplant: Preliminary findings from the phase II ANZHIT-1 study
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia | Haematologica
![PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine](https://www.researchgate.net/publication/317129185/figure/fig1/AS:498185873391616@1495788176053/Only-blood-transfusion-in-mouse-model-showed-no-TA-GVHD-Recipients-were-transfused-1ml_Q320.jpg)
PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine
![PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine](https://i1.rgstatic.net/publication/317129185_Anti-CD3_Antibody_Ameliorates_Transfusion-Associated_Graft-Versus-Host_Disease_in_a_Chemotherapy-Based_Mouse_Model_With_Busulfan_and_Fludarabine/links/5927db5ba6fdcc444350b709/largepreview.png)
PDF) Anti-CD3 Antibody Ameliorates Transfusion-Associated Graft-Versus-Host Disease in a Chemotherapy-Based Mouse Model With Busulfan and Fludarabine
![Raul Cordoba, MD, PhD on Twitter: Raul Cordoba, MD, PhD on Twitter:](https://pbs.twimg.com/media/FBBJFwvUcAwfoar.jpg)